Oncternal Therapeutics Inc (NAS:ONCT)
$ 0.5266 0 (0%) Market Cap: 1.56 Mil Enterprise Value: -12.83 Mil PE Ratio: 0 PB Ratio: 0.17 GF Score: 29/100

Q4 2020 Oncternal Therapeutics Inc Earnings Call Transcript

Mar 11, 2021 / 10:00PM GMT
Release Date Price: $127.4 (+10.40%)
Operator

Greetings, and welcome to the Oncternal Therapeutics, Inc. Fourth Quarter 2020 Financial Results Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Richard Vincent, Chief Financial Officer of Oncternal Therapeutics. Thank you, sir. You may begin.

Richard G. Vincent
Oncternal Therapeutics, Inc. - CFO, Treasurer & Secretary

Thank you, Victor. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and our acting Chief Medical Officer, Dr. Edwina Baskin-Bey, who has been working with us as a consultant for the past several months. We welcome all of you.

Today's call includes a business update and discussion of our 2020 fourth quarter and full year financial results, which will be followed by Q&A. Today's press release and a replay of today's earnings call will be available on the Investor Relations section of Oncternal's website for at least the next 30 days. We filed our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot